Gennex Laboratories Board of Directors

Get the latest insights into the leadership at Gennex Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Arihant Baid Managing Director
Dr. S Dharma Rao Non Executive Director
Dr. A R R Pantulu Non Executive Director
Mr. Mohammed Khaleequr Rahman Non Executive Director
Mr. A S Nageswar Rao Independent Director
Mr. Y Ravinder Reddy Independent Director
Ms. Sadhana Bhansali Independent Woman Director

Gennex Laboratories Share price

GENNEX

11.48

0.00 (0.00%)
Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High

11.80

Today's Low

11.44

52 Week Low

11.15

52 Week High

29.00

The current prices are delayed, login to your account for live prices

Gennex Laboratories FAQs

The board at Gennex Laboratories consists of experienced professionals, including Mr. Arihant Baid , Dr. S Dharma Rao , and others, overseeing the company’s strategic and corporate governance.

Directors at Gennex Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Arihant Baid is the current chairman at Gennex Laboratories.

Executive directors at Gennex Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Gennex Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Gennex Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.